Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AMN Healthcare ServicesAMN -3.23%63 3-Year EBITDA Growth Rate is -46.80% as of Mar. 2026. GuruFocus rates AMN with a GF Score™ of 63/100 and a GF Value™ of $30.32 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 525 Healthcare Providers & Services companies, AMN Healthcare Services ranks worse than 96.38% on this metric.
During the past 12 months, AMN Healthcare Services's average EBITDA Per Share Growth Rate was 405.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -46.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -23.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 1.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AMN Healthcare Services was 91.30% per year. The lowest was -46.80% per year. And the median was 17.80% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
AMN Healthcare Services 3-Year EBITDA Growth Rate Related Terms
AMN vs USPH, PNTG, ARDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, AMN Healthcare Services's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMN Healthcare Services 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AMN Healthcare Services's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where AMN Healthcare Services's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -46.80% mean?
AMN Healthcare Services (AMN) has a 3-Year EBITDA Growth Rate of -46.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AMN Healthcare Services and its competitors. According to the industry distribution chart, AMN Healthcare Services ranks #506 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 96.4%.
Is AMN Healthcare Services' 3-Year EBITDA Growth Rate too high?
AMN Healthcare Services' current 3-Year EBITDA Growth Rate is -46.80%. Based on the distribution chart, AMN Healthcare Services ranks #506 out of 525 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, AMN Healthcare Services has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AMN Healthcare Services' 3-Year EBITDA Growth Rate compare to USPH and PNTG?
According to the Healthcare Providers & Services industry distribution chart, AMN Healthcare Services ranks #506 out of 525 companies for 3-Year EBITDA Growth Rate. This places AMN Healthcare Services in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AMN Healthcare Services and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMN Healthcare Services's current 3-Year EBITDA Growth Rate is -46.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMN Healthcare Services stock overvalued right now?
Based on GuruFocus' analysis, AMN Healthcare Services (AMN) is currently considered Modestly Overvalued. The stock's GF Value™ is $30.32, compared to a current price of $33.59 — trading 10.8% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -46.80%. AMN Healthcare Services' overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For AMN Healthcare Services (AMN), the current 3-Year EBITDA Growth Rate is -46.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMN Healthcare Services (AMN) Overvalued in 2026?
Based on GuruFocus' analysis, AMN Healthcare Services stock appears to be overvalued.
The current stock price of $33.59 is trading 10.8% above its estimated GF Value™ of $30.32.
GuruFocus considers AMN Healthcare Services to be Modestly Overvalued.
Key valuation signals for AMN:
3-Year EBITDA Growth Rate: -46.80%
GF Value™: $30.32 vs. price of $33.59 (10.8% above fair value)
No single metric tells the full story. See the AMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
63GF Score
Get the complete analysis for AMN
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMN has been successfully added to your 
